Morgan Stanley Raises Axsome Therapeutics PT to $196, Maintains Overweight Rating

martes, 4 de noviembre de 2025, 1:01 pm ET1 min de lectura
AXSM--

Morgan Stanley Raises Axsome Therapeutics PT to $196, Maintains Overweight Rating

Morgan Stanley Raises Axsome Therapeutics PT to $196, Maintains Overweight Rating

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios